Merck has taken a step to make its antiviral pill available in poor nations, but many obstacles remain for broad access to coronavirus drugs.
Author: Stephanie Nolen
An Experimental H.I.V. Vaccine Fails in Africa
Researchers ended a large trial in South Africa after finding that an experimental vaccine offered little protection.